Berend Olivier

Utrecht University

Berend Olivier obtained a Ph.D. in Neurobiology from Groningen University, the Netherlands. He worked at Solvay Pharmaceuticals for 22 years leading the research and development of new antidepressants, antipsychotics, anxiolytics, and serenics. He was heavily involved in the research and development of fluvoxamine, a marketed antidepressant, anxiolytic, and anti-OCD medication. From 1999 to 2001, he worked in New York to start a biotech company called PsychoGenics Inc., which develops psychiatric and neurological (genetic) models to screen, find, and develop new central nervous system drugs. From 1992 to 2014, he was a Professor of CNS Pharmacology at Utrecht University, the Netherlands, performing research on animal models, brain mechanisms, and pharmacology of psychiatric disorders. Since 2014, he has been developing animal models of male sexual disorders in the hope of finding new medicines for premature and delayed ejaculation.

Berend Olivier

3books edited

6chapters authored

Latest work with IntechOpen by Berend Olivier

Serotonin is an ancient neurotransmitter system involved in various systems and functions in the body and plays an important role in health and disease. The present volume illustrates the broadness of the involvement of serotonergic activity in many processes, focusing particularly on disorders of the brain, including depression, stress and fear, Alzheimer’s disease, aggression, sexual behavior, and neuro-immune disorders. Chapters illustrate techniques and methods used to study the complex role of the serotonergic system in all kinds of processes, present new hypotheses for several brain disorders like sleep and depression, and use mathematical modeling as a tool to advance knowledge of the extremely complex brain and body processes.

Go to the book